Interim results of PATHFINDER, a clinical use study using a methylation-based multi-cancer early detection test.

被引：25

作者：

Beer, Tomasz M.

McDonnell, Charles H.

Nadauld, Lincoln

Liu, Minetta C.

Klein, Eric A.

Reid, Robert Lawrence

Marinac, Catherine

Chung, Karen

Lopatin, Margarita

Fung, Eric T.

Schrag, Deborah

机构：

[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[2] Sutter Hlth, Sacramento, CA USA

[3] Intermt Healthcare, St George, UT USA

[4] Mayo Clin, Rochester, MN USA

[5] Cleveland Clin, Cleveland, OH 44106 USA

[6] Virginia Canc Specialists, US Oncol Res, Fairfax, VA USA

[7] Dana Farber Canc Inst, Boston, MA 02115 USA

[8] GRAIL Inc, Menlo Pk, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3010

引用

页数：2